Item 5.02 |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers |
On November 4, 2022, as previously disclosed, Velodyne Lidar, Inc., a Delaware corporation (“Velodyne” or the “Company”), Ouster, Inc., a Delaware corporation (“Ouster”), Oban Merger Sub, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Ouster (“Merger Sub I”), and Oban Merger Sub II LLC, a Delaware limited liability company and a direct, wholly owned subsidiary of Ouster (“Merger Sub II”), entered into an Agreement and Plan of Merger (the “Merger Agreement”). Pursuant to the Merger Agreement, and subject to the satisfaction or waiver of the conditions specified therein, Merger Sub I will be merged with and into Velodyne (the “First Merger”), with Velodyne surviving the First Merger as a direct, wholly owned subsidiary of Ouster (the “Surviving Corporation”), and as soon as practicable following the First Merger, the Surviving Corporation will be merged with and into Merger Sub II with Merger Sub II surviving as a direct, wholly owned subsidiary of Ouster (the “Second Merger”, and together with the First Merger, the “Mergers”).
On December 11, 2022, the Board of Directors of Velodyne (the “Board”) took actions, effective in December 2022, to preserve compensation-related corporate income tax deductions for Velodyne that might otherwise be disallowed through the operation of Sections 280G and 4999 of the Internal Revenue Code of 1986, as amended (the “Code”), in connection with the Mergers. Specifically, the Board approved the accelerated vesting of equity awards and payment of cash-based awards to Theodore L. Tewksbury III, Velodyne’s Chief Executive Officer. The Board also approved the accelerated payment of cash-based awards to Mark Weinswig, Velodyne’s Chief Financial Officer; and Anurag Gupta, Velodyne’s Executive Vice President, Engineering, in each case as further described below. These actions will mitigate or eliminate the amount of excise tax that may be payable by Drs. Tewksbury and Gupta, and Mr. Weinswig, pursuant to Sections 280G and 4999 of the Code in certain circumstances.
In approving the accelerated vesting and payment of the awards, the Board considered, among other things, the projected value of the corporate income tax deductions that may be lost as a result of the effect of Section 280G and 4999 of the Code and the benefits accruing to Velodyne from reducing the potential tax burden that the Company’s executives may bear in connection with payments associated with the closing of the Merger and thereby providing Drs. Tewksbury and Gupta, and Mr. Weinswig, an additional financial incentive to remain with Velodyne through the closing of the Merger.
With respect to Dr. Tewskbury, the Board approved the accelerated vesting of 436,343 performance vesting restricted stock awards (“PSAs”), which were scheduled to vest on February 28, 2023, calculated by assuming that the applicable performance goals were achieved at target performance. As a result of such acceleration, the awards will vest on December 23, 2022. The estimated value of Dr. Tewksbury’s accelerated PSAs is $458,160, based upon the closing price of Velodyne’s common stock on December 12, 2022 of $1.05 per share. The foregoing equity awards would have vested upon the earlier of (i) their scheduled vesting date or (ii) the termination of Dr. Tewksbury’s employment without “cause” or his resignation for “good reason” (as each such term is defined in his employment agreement) following the closing of the Merger.
In addition, the Board approved cash payment of $570,000 for Dr. Tewksbury, $175,000 for Mr. Weinswig, and $150,000 for Dr. Gupta (which are expected to be paid on or around December 23, 2022), which represent the early payment of their bonuses for the 2022 fiscal year, calculated by assuming that the applicable performance goals were achieved at 100% of target.